TFC | ||
|---|---|---|
OUTLOOK RATING 1..100 | 76 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 20 Undervalued | |
PROFIT vs RISK RATING 1..100 | 87 | |
SMR RATING 1..100 | 5 | |
PRICE GROWTH RATING 1..100 | 49 | |
P/E GROWTH RATING 1..100 | 48 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| FXO | TFC | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 87% | 2 days ago 64% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 65% |
| MACD ODDS (%) | 7 days ago 67% | 2 days ago 49% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 60% |
| TrendMonth ODDS (%) | 2 days ago 81% | 2 days ago 55% |
| Advances ODDS (%) | 2 days ago 85% | 5 days ago 64% |
| Declines ODDS (%) | 6 days ago 79% | 7 days ago 62% |
| BollingerBands ODDS (%) | 2 days ago 86% | 2 days ago 70% |
| Aroon ODDS (%) | 2 days ago 87% | 2 days ago 61% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BIPIX | 93.22 | N/A | N/A |
| ProFunds Biotechnology UltraSector Inv | |||
| FKARX | 41.33 | N/A | N/A |
| Franklin Growth Opportunities R | |||
| CCWRX | 10.10 | N/A | N/A |
| Columbia Select Large Cap Growth Inst3 | |||
| RAFFX | 46.42 | -0.20 | -0.43% |
| American Funds AMCAP R-5 | |||
| IVIFX | 20.93 | -0.30 | -1.41% |
| Nomura International Core Equity C | |||
A.I.dvisor indicates that over the last year, FXO has been closely correlated with ASB. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if FXO jumps, then ASB could also see price increases.
A.I.dvisor indicates that over the last year, TFC has been closely correlated with KEY. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if TFC jumps, then KEY could also see price increases.